Dear Colleagues,

Following advances in cancer therapy, the majority of adolescents or young adults will become long-term cancer survivors. Young cancer survivors experience a higher risk of infertility than the general population, but individual risk is highly variable depending on cancer type and type and dose of antineoplastic therapy. Fertility loss can be a devastating consequence of cancer treatment for survivors, resulting in poorer quality of life. Prior studies have shown that potential loss of fertility can be as painful as the cancer diagnosis itself, and for some, the possibility of preserving fertility is fundamental to coping with the burden of cancer treatment. Thus, it is mandatory to carry out a fertility consultation before starting antineoplastic treatments.

Fertility counseling before cancer treatment aims to inform patients and families about their future fertility potential and to facilitate the preservation of fertility. The purpose of this Special Issue is to improve knowledge on the gonadotoxicity of oncological and radiotherapy treatments in order to choose and customize the most suitable fertility preservation techniques for men and women.

Furthermore, this collection aims to evaluate the outcomes of spontaneous pregnancies and from in vitro fertilization techniques arising in cancer survivors and perinatal and pediatric follow-up of the births in order to compare them with the general population.

Dr. Eleonora Porcu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• oncofertility
• oocyte cryopreservation
• sperm cryopreservation
• fertility
• reproductive health
• child development